Skip to main content
Fig. 3 | Cancer Nanotechnology

Fig. 3

From: HB5 aptamer-tagged graphene oxide for co-delivery of doxorubicin and silibinin, and highly effective combination therapy in breast cancer

Fig. 3

AFM images (A, B), zeta potential values (C), FTIR spectroscopy measurements (D), and UV–Vis spectral absorbance (E) of cGO and cGO-aptamer. F Agarose gel electrophoresis confirmed the successful HB5 absorption on the cGO surface. AFM: atomic force microscope; FTIR: Fourier transform infrared; UV–Vis: Ultraviolet–visible; cGO: carboxylated Graphene oxide; Apt: aptamer

Back to article page